lirilumab inn human monoclonal antibody designed treatment binds drug developed innate pharma licensed bristolmyers squibb phase clinical trial acute myeloid leukemia terminated early failed registered trial squamous cell carcinoma head neck may november nine clinical trials lirilumab registered immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikilirilumab